Skip to main content

Table 2 Prevalence of genetic defects among Caucasians [15]

From: Hereditary thrombophilia

 

Incident VTE (%)

Recurrent VTE (%)

Normal population

Relative thrombotic risk

Activated Protein C resistance (Factor V Leiden)

20

40–50

3–7

3–7 heterozygotes 50–100 homozygotes

Prothrombin G20210A mutation

3–8

15–20

1–3

2–8 heterozygotes

Antithrombin deficiency

1–2

2–5

0.02–0.04

5

Protein C deficiency

2–5

5–10

0.2–0.5

6–10

Protein S deficiency

1–3

5–10

0.1–1

2